Abstract

In this issue of Blood, van Rhee et al report an evidence and opinion–based framework for treatment of idiopathic multicentric Castleman disease (CD), including consideration of how to assess therapeutic response and the pitfalls found in complex situations.

Original languageEnglish (US)
Pages (from-to)2109-2110
Number of pages2
JournalBlood
Volume132
Issue number20
DOIs
StatePublished - Nov 15 2018

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Do you know TAFRO?'. Together they form a unique fingerprint.

  • Cite this